Use of berbamine for treating chronic myeloid leukemia

The present invention relates to uses of berbamine or a pharmaceutically acceptable salt thereof as a pharmaceutical composition to treat chronic myeloid leukemia, in particular to the Imatinib tolerant chronic myeloid leukemia.